Pembrolizumab for Early-Stage Triple-Negative Breast Cancer: KEYNOTE-522 Japan Subgroup Analysis.
Saved in:
| Title: | Pembrolizumab for Early-Stage Triple-Negative Breast Cancer: KEYNOTE-522 Japan Subgroup Analysis. |
|---|---|
| Authors: | Takahashi M; Department of Breast Surgery, Hokkaido University Hospital, Sapporo, Japan., Mukai H; Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan., Takano T; The Cancer Institute Hospital of JFCR, Tokyo, Japan.; Toranomon Hospital, Tokyo, Japan., Tsugawa K; Department of Breast and Endocrine Surgery, St. Marianna University School of Medicine, Kawasaki, Japan., Inoue K; Department of Breast Care, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan., Itoh M; Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan., Watanabe J; Juntendo University Graduate School of Medicine, Tokyo, Japan., Tanabe Y; Toranomon Hospital, Tokyo, Japan., Yamamoto N; Division of Breast Surgery, Chiba Cancer Center, Chiba, Japan., Miyoshi Y; Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Nishinomiya City, Hyogo, Japan., Watanabe K; NHO Hokkaido Cancer Centre, Sapporo, Japan., Mukohara T; Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan., Kong Y; MSD K.K., Tokyo, Japan., Shimura M; MSD K.K., Tokyo, Japan., Beca F; Global Clinical Development, Merck & Co., Inc., Rahway, New Jersey, USA., Schmid P; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK., Iwata H; Nagoya City University, Nagoya, Japan. |
| Source: | Cancer science [Cancer Sci] 2026 Apr; Vol. 117 (4), pp. 1106-1116. Date of Electronic Publication: 2026 Jan 14. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III |
| Journal Info: | Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41536071 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pembrolizumab for Early-Stage Triple-Negative Breast Cancer: KEYNOTE-522 Japan Subgroup Analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Takahashi+M%22">Takahashi M</searchLink>; Department of Breast Surgery, Hokkaido University Hospital, Sapporo, Japan.<br /><searchLink fieldCode="AU" term="%22Mukai+H%22">Mukai H</searchLink>; Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Takano+T%22">Takano T</searchLink>; The Cancer Institute Hospital of JFCR, Tokyo, Japan.; Toranomon Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tsugawa+K%22">Tsugawa K</searchLink>; Department of Breast and Endocrine Surgery, St. Marianna University School of Medicine, Kawasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Inoue+K%22">Inoue K</searchLink>; Department of Breast Care, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.<br /><searchLink fieldCode="AU" term="%22Itoh+M%22">Itoh M</searchLink>; Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.<br /><searchLink fieldCode="AU" term="%22Watanabe+J%22">Watanabe J</searchLink>; Juntendo University Graduate School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tanabe+Y%22">Tanabe Y</searchLink>; Toranomon Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yamamoto+N%22">Yamamoto N</searchLink>; Division of Breast Surgery, Chiba Cancer Center, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Miyoshi+Y%22">Miyoshi Y</searchLink>; Department of Surgery, Division of Breast and Endocrine Surgery, School of Medicine, Hyogo Medical University, Nishinomiya City, Hyogo, Japan.<br /><searchLink fieldCode="AU" term="%22Watanabe+K%22">Watanabe K</searchLink>; NHO Hokkaido Cancer Centre, Sapporo, Japan.<br /><searchLink fieldCode="AU" term="%22Mukohara+T%22">Mukohara T</searchLink>; Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Kong+Y%22">Kong Y</searchLink>; MSD K.K., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shimura+M%22">Shimura M</searchLink>; MSD K.K., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Beca+F%22">Beca F</searchLink>; Global Clinical Development, Merck & Co., Inc., Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Schmid+P%22">Schmid P</searchLink>; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Iwata+H%22">Iwata H</searchLink>; Nagoya City University, Nagoya, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101168776%22">Cancer science</searchLink> [Cancer Sci] 2026 Apr; Vol. 117 (4), pp. 1106-1116. <i>Date of Electronic Publication: </i>2026 Jan 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley+Publishing+on+behalf+of+the+Japanese+Cancer+Association%22">Wiley Publishing on behalf of the Japanese Cancer Association </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101168776 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1349-7006 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213479032%22">13479032 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41536071 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/cas.70307 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1106 Titles: – TitleFull: Pembrolizumab for Early-Stage Triple-Negative Breast Cancer: KEYNOTE-522 Japan Subgroup Analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Takahashi M – PersonEntity: Name: NameFull: Mukai H – PersonEntity: Name: NameFull: Takano T – PersonEntity: Name: NameFull: Tsugawa K – PersonEntity: Name: NameFull: Inoue K – PersonEntity: Name: NameFull: Itoh M – PersonEntity: Name: NameFull: Watanabe J – PersonEntity: Name: NameFull: Tanabe Y – PersonEntity: Name: NameFull: Yamamoto N – PersonEntity: Name: NameFull: Miyoshi Y – PersonEntity: Name: NameFull: Watanabe K – PersonEntity: Name: NameFull: Mukohara T – PersonEntity: Name: NameFull: Kong Y – PersonEntity: Name: NameFull: Shimura M – PersonEntity: Name: NameFull: Beca F – PersonEntity: Name: NameFull: Schmid P – PersonEntity: Name: NameFull: Iwata H IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2026 Apr Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1349-7006 Numbering: – Type: volume Value: 117 – Type: issue Value: 4 Titles: – TitleFull: Cancer science Type: main |
| ResultId | 1 |